Journalism of Courage
Dr Reddy's Laboratories
DR REDDY'S LABORATORIES NEWS
JB Chemicals gets board approval to acquire Dr Reddy's 4 brands
June 30, 2022 2:42 pm
JB Chemicals & Pharmaceuticals has inked a pact with Dr Reddy's Laboratories to acquire four of its brands -- Z&D, Pedicloryl, Pecef and Ezinapi -- for the India market
Input costs, slow sales crimp India Inc profits
August 02, 2021 10:44 am
The Q1FY22 numbers must be read in the context of the very weak base from a year-on-year perspective and a slightly strong base effect on a quarter-on-quarter basis.
Dr Reddy’s: Sputnik V will start arriving in this quarter
April 15, 2021 2:39 am
The availability of the vaccine in India will, however, depend ultimately on factors such as the number of doses that the government wishes to procure, the price, and the capacity of the country's cold chain system to distribute the vaccine.
Dr Reddy's ADRs list on NSE International Exchange
December 09, 2020 1:42 pm
The secondary listing of Dr Reddy's American Depository Receipts (ADRs) at NSE IFSC would provide global investors an additional venue to transact in their ADRs, the National Stock Exchange (NSE) said in a statement on Wednesday.
Dr Reddy's Q2 profit falls 30% at Rs 762 crore
October 28, 2020 3:16 pm
On October 22, the company experienced an information security incident and consequently isolated the impacted IT services. This incident involved a ransom-ware attack, Dr Reddy's said.
India trials for Russia's Sputnik-V vaccine could start in next few weeks
September 22, 2020 6:53 pm
The trials are part of a deal between the Russian Direct Investment Fund (RDIF) and Dr Reddy’s, in which the Indian firm will conduct Phase III studies in India, pursue local regulatory approvals and, subject to approval, distribute the finished vaccine product in India.
Dr Reddy's shares extend rally; zoom nearly 10%
September 18, 2020 1:59 pm
Continuing its rally for the fourth consecutive day, Dr Reddy's Laboratories stock gained 9.86 per cent to Rs 5,302.85 -- its record high level -- on the BSE. At the NSE, it zoomed 9.79 per cent to an all-time high of Rs 5,300.
COVID-19 related uncertainties may continue in current fiscal: Dr Reddy's
July 06, 2020 5:24 pm
The stockpiling of OTC products is expected to continue in the short-term, and result in demand surges for those drugs.
Dr Reddy's Laboratories posts Q3 loss at Rs 570 crore
January 27, 2020 12:54 pm
The consolidated revenues of the company in the October-December period increased to Rs 4,383.8 crore, over Rs 3,850 crore in the year-ago period, Dr Reddy's Laboratories said in a filing to BSE.
Chinese strategy: Dr Reddy's outsources part manufacturing to local parties
November 21, 2019 4:31 pm
The products are manufactured either in the plant owned by KRRP in China, or partners in China, or in India by Dr. Reddy's
Advertisement
Best of Express
‘Unforgettable experience’President Murmu shares Rafale moment with pilot Pak falsely claimed it captured
Entertainment'Rs 1 lakh per day, first-class travel, 5-star hotels': Why crores from film budgets are being spent on hair and make-up while writers get paltry amounts
EntertainmentBollywood star who worked with Akshay Kumar, Kangana Ranaut was sentenced to 7 years for rape
Trending'Indian workplaces, most egocentric management’: Techie reveals how a smile during virtual meeting almost cost his job as a senior felt ‘insulted’
TrendingMeta’s co-founder says being a CEO for 13 years was exhausting, shares 2 things that added to strain: 'Being a CEO is a lot more...'
SportsWhose T20 blueprint will succeed? Tall madcap pack of Aussies or India with one daredevil Abhishek Sharma and a classical Shubman Gill?
Advertisement
Advertisement